Evidence map›Paper›PMID 34427363›Full record

ArticleStem cells (Dayton, Ohio)2021

Transient receptor potential vanilloid 4 as a regulator of induced pluripotent stem cell chondrogenesis.

Vincent P Willard, Holly A Leddy, Daniel Palmer, Chia-Lung Wu, Wolfgang Liedtke, Farshid Guilak

Open access · greenAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Bioactive materials · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. [Research progress of chondrocyte mechanotransduction mediated by TRPV4 and PIEZOs].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Review
  13. CaInternational journal of molecular sciences · 2023
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Vincent P WillardCytex Therapeutics, Inc, Durham, North Carolina, USA.
Holly A LeddyShared Materials Instrumentation Facility, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-1604-2876
Daniel PalmerDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri, USA.
Chia-Lung WuDepartment of Orthopaedic Surgery, Washington University, St. Louis, Missouri, USA.
Wolfgang LiedtkeRegeneron Pharmaceuticals, Tarrytown, New York, USA.
Farshid GuilakCytex Therapeutics, Inc, Durham, North Carolina, USA.ORCID 0000-0001-7380-0330
Washington University in St. Louis · USCytex Therapeutics (United States) · USDuke University · USRegeneron (United States) · US

Funding

VISCOELASTIC PROPERTIES OF NORMAL AND OA CHONDRONSR01AG015768 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 1998 to 2022
$7.7M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Deborah J Lenschow, Christine T. Pham · 2018 to 2026
$7.6M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
OBESITY, BIOMECHANICS, AND INFLAMMATION IN OSTEOARTHRITISR01AG046927 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2013 to 2023
$3.2M
Deconstructing Cartilage Mechanotransduction by Piezo ChannelsR01AR072999 · NIAMS · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2020 to 2024
$2.9M
Epigenetic Regulation of Chondrogenesis and Cartilage DevelopmentR00AR075899 · NIAMS · UNIVERSITY OF ROCHESTER · PI WU, CHIA-LUNG · 2021 to 2023
$1.1M
Epigenetic Regulation of Chondrogenesis and Cartilage DevelopmentK99AR075899 · NIAMS · WASHINGTON UNIVERSITY · PI WU, CHIA-LUNG · 2019 to 2020
$180k
NIAMS NIH HHS K99 AR075899NIAMS NIH HHS P30 AR073752NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R00 AR075899NIAMS NIH HHS R01 AR072999NIA NIH HHS R01 AG015768NIA NIH HHS R01 AG046927
6 · The paper itself

Abstract

Transient receptor potential vanilloid 4 (TRPV4) is a polymodal calcium-permeable cation channel that is highly expressed in cartilage and is sensitive to a variety of extracellular stimuli. The expression of this channel has been associated with the process of chondrogenesis in adult stem cells as well as several cell lines. Here, we used a chondrogenic reporter (Col2a1-GFP) in murine induced pluripotent stem cells (iPSCs) to examine the hypothesis that TRPV4 serves as both a marker and a regulator of chondrogenesis. Over 21 days of chondrogenesis, iPSCs showed significant increases in Trpv4 expression along with the standard chondrogenic gene markers Sox9, Acan, and Col2a1, particularly in the green fluorescent protein positive (GFP+) chondroprogenitor subpopulation. Increased gene expression for Trpv4 was also reflected by the presence of TRPV4 protein and functional Ca

Indexed as

ChondrogenesisInduced Pluripotent Stem CellsTRPV Cation ChannelsAnimalsCartilageCell DifferentiationCells, CulturedChondrocytesMiceTrpv4 protein, mouseTRPV Cation Channelsadipose stem cellhypertrophymesenchymal stem celltissue engineeringTRP channel

Identifiers

PMID34427363
PMCPMC8743138
OpenAlexW3193422097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.